Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,033 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: Orlando FL, Tampa FL, St. Petersburg FL,
Sponsor: DiscGenics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07254806

Phase 3, Recruiting
Active & Responsive

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

for
Osteoarthritis, Knee, Diabetic Neuropathic Pain,
Location: Winter Park FL, Maitland FL, DeLand FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05986292

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

for
Knee Osteoarthritis
Location: Winter Park FL, North Charleston SC, Birmingham AL,
Sponsor: Doron Therapeutics Inc.

Sex: All

Age: 40 - 70+

Code: NCT07219771

Phase 3, Recruiting
Active & Responsive

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Winter Park FL, Orlando FL, Weston FL, Miami FL,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684144

Phase 3, Recruiting
Active & Responsive

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

for
COVID-19
Location: Winter Park FL, McKinney TX, Miami Lakes FL, Miami FL,
Sponsor: Ocugen

Sex: All

Age: 18+

Code: NCT05258669

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

for
Lumbar Disc Disease
Location: Winter Park FL, Tampa FL, St. Petersburg FL,
Sponsor: BioRestorative Therapies

Sex: All

Age: 18+

Code: NCT04042844

Phase 2, Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Winter Park FL, Tampa CO, New Port Richey FL,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting
Active & Responsive

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

for
PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease
Location: Maitland FL, Hallandale FL, Farmington Hills MI
Sponsor: Serina Therapeutics

Sex: All

Age: 40 - 70+

Code: NCT07422675

Phase 1, Recruiting
Active & Responsive

Confirmatory Clinical Study in Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Orlando FL, Miami FL, Palmetto Bay FL, Fayetteville NC,
Sponsor: MRM Health NV

Sex: All

Age: 16+

Code: NCT07296315

Phase 2, Recruiting
Active & Responsive

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

for
Smoking
Location: Maitland FL, Orlando FL, Hollywood FL, Miami FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07223840

Phase 2, Recruiting
Active & Responsive

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),
Location: Maitland FL, Rockledge FL, Raleigh NC, Winston-Salem NC,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06747351

Phase 3, Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Maitland FL, Altamonte Springs FL, Tampa FL,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase 3, Recruiting
Active & Responsive

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Maitland FL, Tampa FL, Miami Gardens FL, Miami FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06966401

Phase 3, Recruiting
Active & Responsive

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

for
Major Depressive Disorder (MDD), Depression in Adults,
Location: Maitland FL, Tampa FL, Jacksonville FL, Naples FL,
Sponsor: Cybin IRL Limited

Sex: All

Age: 18 - 70+

Code: NCT06793397

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for
Rheumatoid Arthritis
Location: Orlando FL, Avon Park FL, Tampa FL, Clearwater FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase 2, Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: Orlando FL, Kissimmee FL, Lakewood Rch FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

for
Essential Tremor, Movement Disorders, Essential Tremor,
Location: Orlando FL, Memphis TN, Louisville KY, Houston TX,
Sponsor: CND Life Sciences

Sex: All

Age: 50 - 70+

Code: NCT07428447

Recruiting
Active & Responsive

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

for
Parkinson Disease
Location: Orlando FL, Tampa FL, Boca Raton FL, Hallandale FL,
Sponsor: Appello Pharmaceuticals, Inc.

Sex: All

Age: 30 - 70+

Code: NCT07432958

Phase 2, Recruiting
Active & Responsive

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

for
Overweight , Obesity, Adults
Location: Orlando FL, Bradenton FL, Doral FL, Woodstock GA,
Sponsor: Alveus Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07837973

Phase 2, Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: Orlando FL, Mt. Dora FL, The Villages FL,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando